Basics Design Therapeutics, Inc. IPO Date: March 29, 2021 Sector: Healthcare Industry: Biotech Market Cap: $220.26M Activated in VL: True Average Daily Range Avg Daily Range: $0.37 | 3.56% Avg Daily Range (30 D): $0.19 | 4.90% Avg Daily Range (90 D): $0.19 | 4.54% Institutional Daily Volume Avg Daily Volume: .24M Avg Daily Volume (30 D): .08M Avg Daily Volume (90 D): .11M Trade Size Avg Trade Size (Sh.): 92 Avg Trade Size (Sh.) (30 D): 71 Avg Trade Size (Sh.) (90 D): 75 Institutional Trades Total Inst.Trades: 268 Avg Inst. Trade: $1.64M Avg Inst. Trade (30 D): $.51M Avg Inst. Trade (90 D): $.97M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.38M Avg Closing Trade (30 D): $1.7M Avg Closing Trade (90 D): $1.7M Avg Closing Volume: 186.59K         News May 7, 2024 @ 10:30 AM Design Therapeutics to Participate in the 2024 RBC... Source: Design Therapeutics, Inc. Mar 26, 2024 @ 11:37 AM Design Therapeutics And 2 Other Stocks Under $5 In... Source: Avi Kapoor Mar 19, 2024 @ 8:01 PM Design Therapeutics Outlines Progress Across GeneT... Source: Design Therapeutics, Inc. Mar 12, 2024 @ 10:30 AM Design Therapeutics to Webcast Fourth Quarter and ... Source: Design Therapeutics, Inc. Dec 18, 2023 @ 5:00 PM Design Therapeutics, Inc. (DSGN) Upgraded to Buy: ... Source: Zacks Equity Research Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.99 $-.31 $-.24 Diluted EPS $-.99 $-.31 $-.24 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -56.2M $ -17.72M $ -13.65M Operating Income / Loss $ -68.4M $ -20.42M $ -16.69M Cost of Revenue $ $ $ Net Cash Flow $ -15.73M $ -8.9M $ -7.77M PE Ratio